[1]Patent:WO2007/87548,2007,A2.Locationinpatent:Page/Pagecolumn47
[2]Patent:US2012/178748,2012,A1.Locationinpatent:Page/Pagecolumn49
[3]JournalofHeterocyclicChemistry,1988,vol.25,p.129-137
[4]Patent:WO2015/42397,2015,A1.Locationinpatent:Paragraph000822
[1]Patent:US2012/178748,2012,A1.Locationinpatent:Page/Pagecolumn49
[2]Patent:EP242341,1987,A1
[3]Patent:WO2007/87548,2007,A2.Locationinpatent:Page/Pagecolumn46-47
[4]ACSMedicinalChemistryLetters,2015,vol.6,p.359-362
[5]Patent:WO2005/61465,2005,A1.Locationinpatent:Page/Pagecolumn62
[6]JournalofHeterocyclicChemistry,1988,vol.25,p.129-137
[7]Patent:US5624935,1997,A
[8]Patent:WO2010/132999,2010,A1.Locationinpatent:Page/Pagecolumn133
[9]Patent:WO2015/42397,2015,A1.Locationinpatent:Paragraph000821
[1]JournalofMedicinalChemistry,2000,vol.43,p.3052-3066
[1]Heterocycles,2005,vol.65,p.1121-1137
[1]Heterocycles,2005,vol.65,p.1121-1137
[2]Heterocycles,2005,vol.65,p.1121-1137
Title: Discovery of piperazinylimidazo[1,2-a]pyridines as novel S4 binding elements for orally active factor Xa inhibitors.
Journal: Bioorganic & medicinal chemistry 20080315